The next Quarterly Report should be out either 31/01/20 or 3/02/20 based on the companies previous reporting history. The forward plan as released in the Sept Quarterly is as follows:
Follow up reporting summaries during the current quarter include:
Although massively abridged the above does provide a snapshot of progress during the last quarter, ignoring all the corporate activities. I also included the release on the 16/01/20 regarding the Buckle Gold Mineralisation for information. Looks like they have undertaken and reported a lot of what was anticipated (tick for management). It will be interesting if the results of the financial modelling are included in the coming quarterly as that will help better understand the economics of the project and, assuming all is positive, will assist in raising additional capital going forward. Additionally we may get information with regards to the resource upgrade which will also help with the above and possibly a share value re-rate!
The Annual General Meeting is also close:
Being from WA I will be attending and hope to gain a much better understanding of the project and the people that are leading the charge.
- Forums
- ASX - By Stock
- DEG
- Next Quarterly Report
Next Quarterly Report, page-3
Featured News
Add DEG (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.38 |
Change
0.018(1.29%) |
Mkt cap ! $3.307B |
Open | High | Low | Value | Volume |
$1.34 | $1.40 | $1.33 | $6.693M | 4.856M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 36816 | $1.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.38 | 74339 | 44 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 30345 | 1.375 |
29 | 126960 | 1.370 |
10 | 81462 | 1.365 |
14 | 206883 | 1.360 |
6 | 28820 | 1.355 |
Price($) | Vol. | No. |
---|---|---|
1.380 | 47598 | 38 |
1.385 | 89977 | 17 |
1.390 | 172841 | 14 |
1.395 | 53162 | 10 |
1.400 | 393149 | 7 |
Last trade - 15.01pm 13/11/2024 (20 minute delay) ? |
Featured News
DEG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online